A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration
Clinical trial NCT04239027 · COMPLETED
Trial details
- NCT number
- NCT04239027
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2022-05-23
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.